Mammalian Expression Vector SV40 Enhancer Hbb Intron

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current mammalian expression vectors require multiple selection steps and multiple copies of gene integration to achieve high expression levels, making cell line development time-consuming and inefficient, especially for predicting stable expression of secreted proteins.

Innovation Solution

The use of mammalian expression vectors combining the simian virus 40 enhancer and early promoter region with the human Hbb intronII, allowing for single-step selection with G418 or MTX, which enables high and reproducible expression of genes of interest without the need for multiple gene copies or selection steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If multiple selection steps and multiple copies of gene integration are used to achieve high expression levels, then expression level is improved, but cell line development time and workload increase

Engineering Contradiction:
Improveexpression levelVSAvoidcell line development time
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The patent changes the parameters of the expression vector by incorporating specific regulatory elements (SV40 enhancer and early promoter region, Hbb intronII) to achieve high expression levels through qualitative improvement rather than quantitative multiplication. This allows single-copy integration with single-step selection, resolving the contradiction between expression level and development time.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If multiple selection steps are performed to generate high producing cell pool, then expression level is improved, but productivity decreases

Engineering Contradiction:
Improveexpression levelVSAvoidcell line development efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent modifies the vector parameters by incorporating specific regulatory elements that enable high expression from single-copy integration. This allows progression from multiple selection steps to single-step selection, thereby improving productivity while maintaining high expression levels.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If transient expression levels are determined using intracellular reporter proteins, then measurement is simplified, but prediction accuracy of stable expression levels decreases

Engineering Contradiction:
Improvemeasurement simplicityVSAvoidprediction accuracy of stable expression
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent changes the regulatory element parameters to create a system where transient and stable expression are better correlated. The specific combination of SV40 enhancer/promoter and Hbb intronII regulates both intracellular and secreted protein expression, improving the predictive value of transient expression assays for stable production levels.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentEP2367943B1Mammalian expression vector
Publication Date: 2017.03.01 LEK PHARMA D D
  • EP2367943B1 patent drawingFigure 1
  • EP2367943B1 patent drawingFigure 2
  • EP2367943B1 patent drawingFigure 3

AI summary

The present invention describes new mammalian expression vectors comprising a novel combination of regulatory elements and one or more selection marker gene(s). The vector allows for incorporation of at least one, preferably two or more genes of interest, its/their subsequent expression, and for selection of transfected cells using, e.g., G418 and/or MTX. The pDGP?GOI vector as an example for a mammalian expression vector according to the present invention exhibits a 9555 bp sequence, one strand of which is represented by SEQ ID NO:2.